Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 6:26 PM
Ignite Modification Date:
2025-12-25 @ 3:56 PM
NCT ID:
NCT04503668
Group ID:
EG001
Title:
Olanzapine
Description:
Olanzapine will be given on days 1-4 of each 3-week chemotherapy cycle, for up to 6 cycles.
Ondansetron: 8 mg IV or 16 mg by mouth on day 1 pre-chemotherapy; then 8 mg by mouth twice a day on days 2-4 of chemotherapy
Dexamethasone: 20 mg IV on day 1 pre-chemotherapy
Olanzapine: 5 mg by mouth on days 1-4 of chemotherapy (taken at night)
Compazine: 5-10 mg by mouth, available as needed, every 6 hours, days 1-5
Deaths Number Affected:
6
Deaths Number At Risk:
None
Serious Number Affected:
5
Serious Number At Risk:
24
Other Number Affected:
23
Other Number At Risk:
24
Study:
NCT04503668
Results Section:
NCT04503668
Adverse Events Module:
NCT04503668